NATCO PHARMA LTD. - NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country
02 Jan 2017
Natco Pharma Ltd has informed BSE regarding a Press Release dated January 02, 2017 titled "NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country".
Source:
BSE India